AMICUS THERAPEUTICS INC's ticker is and the CUSIP is 03152WAB5. A total of 2 filers reported holding AMICUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $10,877,000 | +57.1% | 2,825,000 | 0.0% | 0.10% | +28.0% |
| Q3 2020 | $6,924,000 | -5.4% | 2,825,000 | 0.0% | 0.08% | -13.8% |
| Q2 2020 | $7,320,000 | +53.9% | 2,825,000 | 0.0% | 0.09% | +2.4% |
| Q1 2020 | $4,756,000 | -3.1% | 2,825,000 | 0.0% | 0.08% | +107.3% |
| Q4 2019 | $4,909,000 | +15.0% | 2,825,000 | 0.0% | 0.04% | +2.5% |
| Q3 2019 | $4,269,000 | -34.8% | 2,825,000 | -5.8% | 0.04% | -32.2% |
| Q2 2019 | $6,548,000 | – | 3,000,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Warberg Asset Management LLC | 2,800,000 | $4,520,000 | 1.50% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |